Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer. | Front Oncol | 2022 | 36158688 | PubTator, text mining | PubMed |
| High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer. | J Oncol | 2022 | 36157241 | PubTator, text mining | PubMed |
| Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry. | Life (Basel) | 2022 | 36143338 | PubTator, text mining | PubMed |
| Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data. | Genes (Basel) | 2022 | 36140740 | PubTator, text mining | PubMed |
| Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma. | Cancers (Basel) | 2022 | 36139618 | PubTator, text mining | PubMed |
| Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population. | Cells | 2022 | 36139351 | PubTator, text mining | PubMed |
| Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function. | Eur J Pharmacol | 2022 | 36122756 | PubTator, text mining | PubMed |
| Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. | Nat Med | 2022 | 36097216 | PubTator, text mining | PubMed |
| Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma. | J Gastrointest Oncol | 2022 | 36092338 | PubTator, text mining | PubMed |
| Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. | Front Immunol | 2022 | 36090985 | PubTator, text mining | PubMed |
| Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma. | J Oncol | 2022 | 36090900 | PubTator, text mining | PubMed |
| Characterization of KIR+CD8+ Regulatory T Cells in Humans by scRNA- and TCR-seq. | Methods Mol Biol | 2022 | 36087198 | PubTator, text mining | PubMed |
| Targeting CD38 in Neoplasms and Non-Cancer Diseases. | Cancers (Basel) | 2022 | 36077708 | PubTator, text mining | PubMed |
| Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine. | Front Immunol | 2022 | 36072604 | PubTator, text mining | PubMed |
| Strategies to induce natural killer cell tolerance in xenotransplantation. | Front Immunol | 2022 | 36072599 | PubTator, text mining | PubMed |
| TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM). | Front Surg | 2022 | 36061054 | PubTator, text mining | PubMed |
| Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis. | Front Immunol | 2022 | 36059513 | PubTator, text mining | PubMed |
| Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies. | Front Immunol | 2022 | 36045670 | PubTator, text mining | PubMed |
| LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer. | Sci Rep | 2022 | 36042287 | PubTator, text mining | PubMed |
| Structure of the human NK cell NKR-P1:LLT1 receptor:ligand complex reveals clustering in the immune synapse. | Nat Commun | 2022 | 36028489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=17